Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells

References

• Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006;24:2137–2150.10.1200/JCO.2005.05.2308
   PubMed Web of Science ®Google Scholar
• Movva S, Rodriguez L, Arias-Pulido H, Verschraegen C. Novel chemotherapy approaches for cervical cancer. Cancer. 2009;115:3166–3180.10.1002/cncr.v115:14
   PubMedGoogle Scholar
• Zur HH. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2002;2:342–350.
   PubMed Web of Science ®Google Scholar
• Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O’Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int. J. Cancer. 2013;132:854–867.10.1002/ijc.27713
   PubMed Web of Science ®Google Scholar
• Ganguly N, Parihar SP. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis. J. Biosci. 2009;34:113–123.10.1007/s12038-009-0013-7
   PubMed Web of Science ®Google Scholar
• Smith JS, Green J, Berrington DGA, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361:1159–1167.10.1016/S0140-6736(03)12949-2
   PubMed Web of Science ®Google Scholar
• Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett. 2008;582:2093–2101.10.1016/j.febslet.2008.04.039
   PubMed Web of Science ®Google Scholar
• Boureux A, Vignal E, Faure S, Fort P. Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol. Biol. Evol. 2007;24:203–216.
   PubMed Web of Science ®Google Scholar
• Wherlock M, Mellor H. The Rho GTPase family: a Racs to Wrchs story. J. Cell Sci. 2002;115:239–240.
   PubMed Web of Science ®Google Scholar
• Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005;21:247–269.10.1146/annurev.cellbio.21.020604.150721
   PubMed Web of Science ®Google Scholar
• Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem. J. 2000;348:241–255.10.1042/0264-6021:3480241
   PubMed Web of Science ®Google Scholar
• Wilkins A, Insall RH. Small GTPases in Dictyostelium: lessons from a social amoeba. Trends Genet. 2001;17:41–48.10.1016/S0168-9525(00)02181-8
   PubMed Web of Science ®Google Scholar
• Aronheim A, Broder YC, Cohen A, Fritsch A, Belisle B, Abo A. Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr. Biol. 1998;8:1125–1128.10.1016/S0960-9822(98)70468-3
   PubMed Web of Science ®Google Scholar
• Gomez DPT, Benitah SA, Valeron PF, Espina C, Lacal JC. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays. 2005;27:602–613.
   PubMed Web of Science ®Google Scholar
• Gouw LG, Reading NS, Jenson SD, Lim MS, Elenitoba-Johnson KS. Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br. J. Haematol. 2005;129:531–533.10.1111/bjh.2005.129.issue-4
   PubMedGoogle Scholar
• Benitah SA, Valeron PF, van Aelst L, Marshall CJ, Lacal JC. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim. Biophys. Acta. 2004;1705:121–132.
   PubMed Web of Science ®Google Scholar
• Merajver SD, Usmani SZ. Multifaceted role of Rho proteins in angiogenesis. J. Mammary Gland Biol. Neoplasia. 2005;10:291–298.10.1007/s10911-006-9002-8
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Xiang L, Lee SJ, Chaturvedi P, Hubbi ME, Wirtz D, Semenza GL. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc. Nat. Acad. Sci. USA. 2014;111:E384–E393.10.1073/pnas.1321510111
   PubMed Web of Science ®Google Scholar
• Hauser AD, Bergom C, Schuld NJ, Chen X, Lorimer EL, Huang J, Mackinnon AC, Williams CL. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer. Mol. Cancer Res. 2014;12:130–142.10.1158/1541-7786.MCR-13-0362
   PubMed Web of Science ®Google Scholar
• Patlolla JM, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV. Beta-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prev. Res (Phila). 2013;6:1140–1149.10.1158/1940-6207.CAPR-13-0216
   PubMed Web of Science ®Google Scholar
• Carr HS, Zuo Y, Oh W, Frost JA. Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1. Mol. Cell Biol. 2013;33:2773–2786.10.1128/MCB.00175-13
   PubMed Web of Science ®Google Scholar
• Hamadmad SN, Hohl RJ. Erythropoietin stimulates cancer cell migration and activates RhoA protein through a mitogen-activated protein kinase/extracellular signal-regulated kinase-dependent mechanism. J. Pharmacol. Exp. Ther. 2008;324:1227–1233.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392:189–193.10.1016/0014-5793(96)00811-3
   PubMed Web of Science ®Google Scholar
• Ryan MD, King AM, Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 1991;72:2727–2732.10.1099/0022-1317-72-11-2727
   PubMed Web of Science ®Google Scholar
• Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DA. Correction of multi-gene deficiency in vivo using a single “self-cleaving” 2A peptide-based retroviral vector. Nat. Biotechnol. 2004;22:589–594.10.1038/nbt957
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer J. Clin. 2005;55:74–108.10.3322/canjclin.55.2.74
   PubMed Web of Science ®Google Scholar
• Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene. 2010;29:1293–1302.10.1038/onc.2009.420
   PubMed Web of Science ®Google Scholar
• Ariake K, Ohtsuka H, Motoi F, Douchi D, Oikawa M, Rikiyama T, Fukase K, Katayose Y, Egawa S, Unno M. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett. 2012;325:99–107.10.1016/j.canlet.2012.06.012
   PubMed Web of Science ®Google Scholar
• Liao YC, Ruan JW, Lua I, Li MH, Chen WL, Wang JR, Kao RH, Chen JH. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene. 2012;31:3086–3097.10.1038/onc.2011.476
   PubMed Web of Science ®Google Scholar
• Szymczak-Workman AL, Vignali KM, Vignali DA. Verification of 2A peptide cleavage. Cold Spring Harb. Protoc. 2012;2012:255–257.
   PubMedGoogle Scholar